4
Changes in Ownership
CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001209191-22-062654
Director bought 667 shares at an average $2.23 ($1,487)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Jones James Director | 2022-12-01 | Purchase | +31 | $2.33 | $72 | 25,657 | D |
| Jones James Director | 2022-12-02 | Purchase | +31 | $2.31 | $72 | 25,688 | D |
| Jones James Director | 2022-12-05 | Purchase | +31 | $2.19 | $68 | 25,719 | D |
| Jones James Director | 2022-12-06 | Purchase | +31 | $2.19 | $68 | 25,750 | D |
| Jones James Director | 2022-12-07 | Purchase | +31 | $2.18 | $68 | 25,781 | D |
| Jones James Director | 2022-12-08 | Purchase | +31 | $2.19 | $68 | 25,812 | D |
| Jones James Director | 2022-12-09 | Purchase | +31 | $2.15 | $67 | 25,843 | D |
| Jones James Director | 2022-12-12 | Purchase | +31 | $2.14 | $66 | 25,874 | D |
| Jones James Director | 2022-12-13 | Purchase | +40 | $2.18 | $87 | 25,914 | D |
| Jones James Director | 2022-12-14 | Purchase | +40 | $2.21 | $88 | 25,954 | D |
| Jones James Director | 2022-12-15 | Purchase | +20 | $2.24 | $45 | 25,974 | D |
| Jones James Director | 2022-12-16 | Purchase | +40 | $2.22 | $89 | 26,014 | D |
| Jones James Director | 2022-12-19 | Purchase | +70 | $2.21 | $155 | 26,084 | D |
| Jones James Director | 2022-12-20 | Purchase | +121 | $2.31 | $280 | 26,205 | D |
| Jones James Director | 2022-12-21 | Purchase | +88 | $2.22 | $195 | 26,293 | D |
| Open-market purchases · 667 sh · avg $2.23 · $1,487 | |||||||
Loading xslF345X03/doc4.xml…